Kitazato Corporation

Kitasato Corporation and its group of affiliated companies operate as a single-segment medical equipment business, primarily manufacturing and selling medical devices and reagents for fertility treatment. Through product supply in Japan and overseas, the Group provides medical devices and reagents supporting the egg retrieval, fertilization, culture, cryopreservation and embryo transfer stages of fertility treatment. In Japan, it supplies hospitals and clinics with products including Cryotop, ET catheters and reagents for freezing oocytes and fertilized eggs. Overseas, it supplies its products to approximately 110 countries and regions worldwide. Its overseas distributor network comprises approximately 80 companies globally and is expanding mainly in Europe and the United States. Backed by Made in Japan technology, all products are manufactured domestically at the Shizuoka head office plant and the Tokyo office. The Group develops and manufactures cryopreservation reagents and storage equipment using the ultra-rapid vitrification method and provides freezing programs designed to achieve high survival rates at medical facilities.